...

Module

Mechanisms of Action and Clinical Advances in the Treatment of Non-Hodgkin’s Lymphomas

Source: Spanning the Spectrum of Care: Clinical Advances and Practical Applications in Lymphoma

Mechanisms of Action and Clinical Advances in the Treatment of Non-Hodgkin’s Lymphomas


Faculty:

Deborah A. Frieze, PharmD, BCOPAlice Mohr, RN, MSN, FNP-BC
  • Deborah A. Frieze, PharmD, BCOP
  • Alice Mohr, RN, MSN, FNP-BC

CREDIT INFORMATION

Release Date: 04/23/09

Expiration Date: 04/22/10


Registered Nurses: 1.3 Nursing contact hours

Pharmacists: 1.25 contact hours (0.13 CEUs)

Status: Please log in to view status

Begin the Module

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the mechanisms of action of different classes of targeted agents for treating patients with non-Hodgkin’s lymphomas
  • Discuss different classes of agents being used to treat or investigated for non-Hodgkin’s lymphoma patients
  • Summarize the common toxicities associated with the various classes of agents currently in use or under exploration for the treatment of non-Hodgkin’s lymphomas
  • Cite recent clinical trial results for the treatment of non-Hodgkin’s lymphomas

Topics covered include:

  • Introduction
  • Defining Indolent B-Cell Lymphomas
  • Chemotherapy Agents for Treating Indolent Lymphomas
  • Monoclonal Antibodies for Treating Indolent Lymphomas
  • Radioimmunotherapy for Treating Indolent Lymphoma
  • High-Dose Chemotherapy
  • Vaccine Strategies for Indolent Lymphomas
  • Novel Agents for Treating Indolent Lymphomas
  • Defining Aggressive B-Cell Lymphomas
  • Chemotherapy in Aggressive Lymphomas
  • Monoclonal Antibodies for Treating Aggressive Lymphomas
  • High-Dose Chemotherapy Strategies
  • Novel Therapies for Treating Aggressive Lymphomas
  • Treatment of Mantle Cell Lymphoma and Burkitt’s Lymphoma
  • Treatment of T-Cell Lymphomas
  • Conclusions

Abstract
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Contact Info

Educational grant provided by:

Educational grants support only the CME-certified components of this program.